secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001213900-25-028003
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma raises $2M in registered direct offering; proceeds for LYMPHIR launch
--------------------------------------------------------------------------------

- Offering of 465,000 shares at $1.15 and 1,274,131 pre-funded warrants at $1.1499.
- Net proceeds ~$1.735M after fees; used for commercial launch of LYMPHIR and general corporate purposes.
- Placement agent H.C. Wainwright received 7% cash fee and 121,739 warrants exercisable at $1.4375.
- Company agreed to 30-day lock-up on further equity issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025028003/0001213900-25-028003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025028003/ea0236661-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-028003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer